1/2

Export Ready

Tucaxen Tablets Tucatinib

Name: Tucaxen Tablets Tucatinib
SKU: 8495593
Price: 544.12 USD
Availability: InStock

Sold by Armour Nutrition · Retailer, Brand Owner, Distributor, Exporter, Importer, Wholesaler · Bengaluru, Karnataka, India

Price

₹ 544.12 /Pack

In stock

Inclusive of all taxes

Minimum order: 1 Pack

Export Snapshot

MOQ

1 Pack

Lead time

On request

Packaging

Standard export packaging

Shelf life / longevity

As per product specification

HS Code

On request

Origin

India

Port of dispatch

On request

Export markets served

Global markets

Values shown are for Armour Nutrition.

Compliance & Certifications

Suitable for

Importers · Distributors · Wholesalers

Bengaluru Dispatch on request Verified seller

Armour Nutrition

Retailer, Brand Owner, Distributor, Exporter, Importer, Wholesaler · Bengaluru, Karnataka, India

Registered address: Bengaluru, India. Industry: Healthcare, Medical Supplies & Pharmaceuticals > Health Care Products.

View profile All products

Established

Not shared

Employees

–

GST

29AQTPJ8785C1Z2

IEC code

Not shared

Export markets

Global markets

GlobalLinker Member Since

Aug 2019

Turnover

Incorporation Type

On request

Verified Seller IMPORT EXPORT LICENSE ISSUED BY GOVERMENT OF INDIA GST ISSUED BY GOVERNMENT DRUG LICENSE ISSUED BY HEALTH AUTHORITY GOVERMENT

Product details

What are the specifications of this product?

Overview

Tucaxen Tablets, containing Tucatinib, are prescribed for HER2-positive breast cancer treatment. As a tyrosine kinase inhibitor, Tucatinib targets the HER2 protein to slow cancer cell growth. Suitable for advanced cases, this medication requires adherence to prescribed dosages and monitoring for side effects. Manufactured with high-quality standards, Tucaxen offers a targeted approach to breast cancer therapy.

Product Description

Tucaxen Tablets contain Tucatinib, a tyrosine kinase inhibitor used in the treatment of HER2-positive breast cancer. Tucatinib works by inhibiting the HER2 protein, which promotes the growth of cancer cells. This targeted therapy is typically prescribed for patients with advanced or metastatic breast cancer who have received prior treatments. Each pack contains a specific dosage regimen as prescribed by an oncologist. Patients are advised to follow their healthcare provider's instructions closely and report any side effects promptly. Tucaxen is manufactured under stringent quality standards to ensure its efficacy and safety.

Description provided by Armour Nutrition.

Specifications

Drug Class	Tyrosine Kinase Inhibitor
Target Protein	HER2 protein
Route of Administration	Oral
Packaging Type	Blister pack or strip of tablets
Storage Conditions	Store in a cool, dry place away from direct sunlight
Shelf Life	Typically 24 months from manufacturing date
Recommended Dosage	As prescribed by oncologist, commonly 300 mg twice daily
Common Side Effects	Diarrhea, fatigue, nausea, liver enzyme elevation
Manufacturer	Produced under strict GMP guidelines

Use cases

Category	Pharmaceuticals > Oncology Drugs > Targeted Therapy > Tyrosine Kinase Inhibitors
Primary application	Wholesale, distribution, and international sourcing
Brand	Not specified
Product type	Product

Logistics & handling

Lead time	On request
Packaging	As per buyer requirement
Storage condition	As recommended by supplier
Origin	India
Form	As listed by supplier

Commercials (this seller)

Minimum order	1 Pack
Lead time	On request
Payment terms	As per negotiated commercial agreement.
Checkout type	enquiry

Buyer questions

Frequently asked by buyers

Common questions B2B buyers ask before sourcing Tucaxen Tablets Tucatinib. Answers compiled from verified sellers' commercial terms and platform data.

Q: What is the primary mechanism by which Tucaxen Tablets work against HER2-positive breast cancer?

A: Tucaxen Tablets contain Tucatinib, which selectively inhibits the tyrosine kinase activity of the HER2 protein, preventing cancer cell growth and proliferation.

Q: For which patient group is Tucaxen Tablets most suitable?

A: Tucaxen is prescribed for patients with advanced or metastatic HER2-positive breast cancer who have received prior cancer treatments.

Q: Are there any specific side effects that require monitoring during Tucaxen therapy?

A: Yes, patients should be monitored for side effects such as diarrhea, liver enzyme elevations, fatigue, and nausea during treatment.

Q: How is Tucaxen Tablets administered to patients?

A: Tucaxen is administered orally as tablets, with the dosage and schedule prescribed by an oncologist.

Q: What quality standards are observed in the manufacturing of Tucaxen Tablets?

A: Tucaxen is manufactured under stringent Good Manufacturing Practices (GMP) to ensure safety, efficacy, and consistent pharmaceutical quality.

Q: Can Tucaxen be used as a first-line treatment for HER2-positive breast cancer?

A: No, Tucaxen is typically prescribed for patients who have previously undergone other treatments; it is mainly indicated for advanced or metastatic cases.

Question not answered? Ask sellers directly — typical response within 4 hours.